Several Methods for Early Diagnosis of Alzheimer’s Disease Developed

ScienceDaily (June 15, 2011) — PredictAD is an EU-funded research project that develops objective and efficient methods for enabling earlier diagnosis of Alzheimer’s disease. Diagnosis requires a holistic view of the patient combining information from several sources, such as, clinical tests, imaging and blood samples.

“The aim of the PredictAD project is to develop an objective indicator to diagnose Alzheimer’s disease at the earliest stage possible. Current diagnostic guidelines emphasise the importance of various biomarkers in diagnostics. We have developed novel approaches to extract biomarkers from imaging data, electrophysiological data and blood samples, and a unique and clinically useful software tool for integrating all these heterogeneous measurements.” says the Scientific Coordinator of the project, Dr Jyrki Lötjönen from VTT Technical Research Centre of Finland.

Magnetic resonance imaging for identifying atrophy

 

Atrophy in the mediotemporal lobe is a well-known hallmark of Alzheimer’s disease. Magnetic resonance imaging is an excellent tool for measuring this tissue loss. In current clinical practice, images are interpreted mostly only by visual inspection but there is a great need for objective measurements.

PredictAD has developed several methods to meet this need. “We have managed to develop efficient tools for measuring the size of the hippocampus, the atrophy rate of the hippocampus, and two modern approaches based on comparing patient data with previously diagnosed cases available in large databases.” says the leader of the imaging biomarkers work-package, professor Daniel Rueckert from Imperial College London. Positron emission tomography (PET) imaging is another imaging technology studied in the project. A novel tracer developed recently especially for diagnostics of Alzheimer’s disease provides promises for very early diagnosis of the disease.

Detecting changes in the electrophysiology of the brain

 

Alzheimer’s disease is known to affect the electromagnetic activity of the brain. In PredictAD, we have studied the performance of a novel technology, transcranial magnetic stimulation (TMS) combined with electroencephalographic (EEG) measures in detecting the disease. The strength of TMS/EEG is that it allows direct and non-invasive perturbation of the human cerebral cortex without requiring the subject’s collaboration. Our study has shown significant changes in Alzheimer’s patients compared with healthy aging people.

Non-invasive techniques to find biomarkers of the disease

 

Molecular level biomarkers are currently under extensive studies in Alzheimer’s research. Many biomarkers, such as tau proteins and b-amyloid 42, measured from the cerebrospinal fluid (CSF), the liquid surrounding the cerebral cortex, have been found to be strongly related with the disease. One major challenge of these biomarkers is that taking samples from CSF is an invasive measurement limiting their usability in early diagnostics. Blood samples would be an excellent source for detecting Alzheimer’s disease as blood sampling is not considered an invasive technique. PredictAD has studied the role of metabolomic and protein compounds in Alzheimer’s disease from blood samples. The preliminary results reveal several promising compounds.

Methodology for measuring the state of the patient

 

Currently, clinicians make the final diagnosis by combining heterogeneous measurements with information from interviews of the patient and relatives. This process involves subjective reasoning and requires strong expertise from the clinicians. Modern hospitals have huge data reserves containing hidden information that could be utilised in diagnostics by systematic mathematical modelling.

PredictAD has designed a totally novel approach for measuring objectively the state of the patient. This decision support system, developed in close collaboration with clinicians, compares patient measurements with measurements of other patients in large databases and provides at the end an index and graphical representation reflecting the state of the patient. “The PredictAD tool provides a new option to support decision making,” says Prof. Hilkka Soininen from the University of Eastern Finland, leading the clinical validation of the project.

Possibilities for significant savings in health costs

 

Prof. Gunhild Waldemar from Copenhagen University Hospital, Rigshospitalet emphasises the importance of the Alzheimer’s disease research: “Successful, early diagnostics combined with the novel drugs under development and early psychosocial care may delay the institutionalisation of patients, reducing suffering and the costs to the society. It has been calculated that delaying the onset of the disease by five years would halve all costs of Alzheimer’s disease and delaying onset and progression by only one year would reduce the number of Alzheimer’s cases by about 10%.”

Read more http://www.sciencedaily.com/releases/2011/06/110615062000.htm

Share

Posted: June 16th, 2011 under Uncategorized.

RSS Medical Imaging News

  • Introducing the multi-tasking nanoparticle August 26, 2014
    Dynamic nanoparticles (NPs) have been developed that could provide an arsenal of applications to diagnose and treat cancer. Built on an easy-to-make polymer, these particles can be used as contrast agents to light up tumors for MRI and PET scans or deliver chemo and other therapies to destroy tumors. In addition, the particles are biocompatible and have show […]
  • Wii Balance Board induces changes in brains of people with multiple sclerosis August 26, 2014
    A balance board accessory for a popular video game console can help people with multiple sclerosis (MS) reduce their risk of accidental falls, according to new research. Magnetic resonance imaging scans showed that use of the Nintendo Wii Balance Board system appears to induce favorable changes in brain connections associated with balance and movement.
  • Lung cancer rarely detected by current X-ray procedures August 25, 2014
    Current X-ray examinations capture only 20 percent of cases of lung cancer, researcher say. With modern ultralow-dose CT, the radiologists hit the bull’s eye 90 per cent of the time.
  • Newly patented device could signal best bet for treatment of stroke patients August 21, 2014
    A new device could soon be available to treat stroke more effectively. The ClotBust ER® fits on the head like a halo and delivers therapy to quickly bust clots that cause stroke. The ClotBust ER® has 16 transducers scattered around the inside -- designed to line up with the thin points in the skull: the temples and the foramen magnum in the base of the skull […]
  • White-matter deficits in users of codeine-containing cough syrups August 20, 2014
    An imaging study of chronic users of codeine-containing cough syrups (CCS) has found deficits in specific regions of brain white matter and associates these changes with increased impulsivity in codeine-containing cough syrup users. These findings were consistent with results of previous studies of heroin and cocaine addicts. White matter disruptions also co […]
  • New X-ray imaging lets researchers see 'live' the effectiveness of cystic fibrosis treatments August 15, 2014
    Scientists have developed an X-ray imaging system that enables researchers to see 'live' how effective treatments are for cystic fibrosis. Cystic fibrosis affects many of the body's systems, but most severely the lungs, and currently it can take several months to measure how effective treatment is for the early-fatal lung disease.
  • Double vision: New imaging agent improves surgeon's ability to find, remove cancer August 14, 2014
    It’s a question that both cancer surgeons and patients ask after the removal of a malignant tumor – did the procedure “get” all of the cancer? Scientists have now engineered a hybrid imaging agent that maps out tumors before surgery, and causes cancer cells to glow during surgery – improving the surgeon’s ability to find and remove cancerous lesions while pr […]
  • New non-invasive technique controls size of molecules penetrating the blood-brain barrier August 14, 2014
    The size of molecules penetrating the blood-brain barrier can be controlled using acoustic pressure -— the pressure of an ultrasound beam -— to let specific molecules through, a new technique has demonstrated for the first time. This innovative method may help improve drug delivery to the brain. Most small -- and all large -- molecule drugs do not currently […]
  • Imaging system guides brain tumor removal to improve patient outcomes August 12, 2014
    NIBIB-funded researchers have developed an imaging system that rapidly and accurately detects a molecular marker found in brain gliomas. It promises to improve the precision of these difficult surgeries by enabling the complete removal of the tumor, while reducing residual damage to brain tissue and neural function.
  • Prostate cancer diagnosis improves with MRI technology August 12, 2014
    MRI technology has been melded with a traditional ultrasound prostate exam to create a three-dimensional map of the prostate that allows physicians to view growths that were previously undetectable. "With an ultrasound exam, we are typically unable to see the most suspicious areas of the prostate so we end up sampling different parts of the prostate tha […]

News Items

Links